Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Raza Ur Rehman’s Commentary on Fitusiran for the Management of Hemophilia A and B To Be Published
Raza Ur Rehman/LikedIn
Dec 22, 2025, 16:06

Raza Ur Rehman’s Commentary on Fitusiran for the Management of Hemophilia A and B To Be Published

Raza Ur Rehman, Bachelor of Medicine and Surgery at Shaikh Khalifa bin Zayed Al Nahyan Medical and Dental College, shared on LinkedIn:

”I am pleased to share that my commentary article on Fitusiran, a first-in-class RNA interference (RNAi) therapy for the management of Hemophilia A and Hemophilia B, has been accepted for publication in Health Science Reports (Wiley).

This commentary discusses the evolving role of Fitusiran in rebalancing hemostasis and highlights its clinical significance in the current and future landscape of hemophilia management.

I am grateful to the editorial team at Health Science Reports for their efficient handling of the manuscript and the opportunity to contribute to the scientific discourse in this field.”

Raza Ur Rehman's Commentary on Fitusiran for the Management of Hemophilia A and B To Be Published

Stay updated with Hemostasis Today.

Fitusiran Health Health Science Reports Hematology Hemophilia Hemostasis Hemostasis Today Medicine Raza Ur Rehman RNAi thrombosis Wiley
NewsFeed